GLP-1 Medications Articles - Page 19

GLP-1 Medications Fuel Surge in Meal Replacement Market

The global GLP-1 meal replacement market is experiencing explosive growth, projected to reach USD 10.9 billion by 2036. This surge is directly linked to the increasing adoption of GLP-1 medications like semaglutide and tirzepatide, alongside a growing consumer preference for convenient, nutrient-dense, and high-protein nutrition solutions designed to support weight management and reduced-appetite lifestyles.

Shotlee·May 13, 2026·7 min read

Health Conditions

PCOS Renamed PMOS: A New Era for Endocrine Health

Polycystic Ovary Syndrome (PCOS), a condition affecting millions of women, is undergoing a significant renaming to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change aims to better reflect the condition's complex interplay with endocrine and metabolic systems, potentially improving diagnosis and treatment.

Shotlee·May 12, 2026·8 min read

Health & Wellness

AI Startup Acquires Parkinson's Cell Therapy from Ozempic Maker

Mark Zuckerberg-backed AI startup Cellular Intelligence has acquired global rights to STEM-PD, an experimental Parkinson's disease cell therapy developed by Novo Nordisk, the pharmaceutical giant behind Ozempic and Wegovy. This strategic move signals a new era for AI in accelerating complex therapeutic development.

Shotlee·May 11, 2026·7 min read

Health & Wellness

Amazon Stocks Oral Ozempic Pills: Same-Day Delivery & Pricing Guide

Amazon Pharmacy is expanding access to oral GLP-1 medications like Ozempic and Wegovy through kiosks and same-day delivery. Here is everything you need to know about pricing, logistics, and managing your treatment.

Shotlee·May 10, 2026·7 min read

Healthcare Strategy & Benefits

GLP-1 Costs and Rising Spend: Why Primary Care is the New Cost Strategy

With healthcare costs projected to jump another 9% next year, driven significantly by GLP-1 medications like semaglutide and tirzepatide, employers face unprecedented budget pressure. This article explores why reactive cost-cutting fails and how investing upstream in robust primary care coordination is the key to sustainable financial health and better patient outcomes.

Shotlee·May 10, 2026·6 min read

Health & Wellness

GLP-1 Meds: 8 Things to Avoid for Optimal Weight Loss & Health

Navigating weight loss with GLP-1 medications such as semaglutide and tirzepatide requires careful attention to lifestyle choices. This guide details 8 crucial things to avoid to ensure you experience the full benefits and fewer side effects.

Shotlee·May 10, 2026·8 min read

Health & Wellness

GLP-1 Revolution: Ozempic's Rise and the Shifting Landscape of Weight Loss

Once primarily a diabetes medication, Ozempic and other GLP-1 agonists have experienced an unprecedented rise in popularity, driven by their significant impact on weight loss. This article delves into the data, the science, and the cultural context behind this revolution.

Shotlee·May 9, 2026·6 min read

Health & Wellness

GLP-1 Drugs: Beyond the Hype and into the 'Wild West' of Wellness

GLP-1 agonists are revolutionizing weight management, but their rise has coincided with a surge in online wellness culture, leading to a 'wild west' of unregulated peptide use. This article delves into the science, societal impact, and potential dangers.

Shotlee·May 9, 2026·8 min read

Health & Wellness

GLP-1 Medications: Understanding Ozempic, Wegovy, and Mounjaro

Celebrities and everyday individuals are increasingly discussing their experiences with GLP-1 medications such as Ozempic, Wegovy, and Mounjaro for weight management. This article delves into the science behind these popular drugs, their benefits, potential side effects, and what users can expect.

Shotlee·May 9, 2026·7 min read

GLP-1 Medications

Latest Articles

GLP-1 Medications Fuel Surge in Meal Replacement Market

PCOS Renamed PMOS: A New Era for Endocrine Health

AI Startup Acquires Parkinson's Cell Therapy from Ozempic Maker

Amazon Stocks Oral Ozempic Pills: Same-Day Delivery & Pricing Guide

GLP-1 Costs and Rising Spend: Why Primary Care is the New Cost Strategy

GLP-1 Meds: 8 Things to Avoid for Optimal Weight Loss & Health

GLP-1 Revolution: Ozempic's Rise and the Shifting Landscape of Weight Loss

GLP-1 Drugs: Beyond the Hype and into the 'Wild West' of Wellness

GLP-1 Medications: Understanding Ozempic, Wegovy, and Mounjaro

Mysterious Flat Affect Symptom in GLP-1 Users

Ozempic, Mounjaro & More: Yale Study Exposes Risky Online GLP-1 Prescribing

GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & Allodynia

Beyond Healthspan: The New Midlife Goal for Men

New GLP-1 Weight-Loss Drugs Stronger Than Wegovy and Zepbound